However, comparison of common checkpoints PD–L1 (CD274), PD1 (PDCD1), CTLA4, and LAG3 between male and female patients reveled that sex is not the main factor for the prediction of response to immune checkpoint inhibitors in STS. The gene discussed is CTLA4; the disease is telomere syndrome.